|
NUDT12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47268872044515E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.66922073122578E-12 |
| Normal-vs-Stage2 |
1.87229999948357E-07 |
| Normal-vs-Stage3 |
2.61239999999052E-06 |
| Normal-vs-Stage4 |
7.138600E-03 |
| Stage1-vs-Stage2 |
9.993800E-01 |
| Stage1-vs-Stage3 |
5.732800E-01 |
| Stage1-vs-Stage4 |
1.400600E-01 |
| Stage2-vs-Stage3 |
6.982000E-01 |
| Stage2-vs-Stage4 |
2.277000E-01 |
| Stage3-vs-Stage4 |
4.017000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69100289326707E-11 |
| Normal-vs-AfricanAmerican |
2.48440046313192E-10 |
| Normal-vs-Asian |
8.342900E-03 |
| Caucasian-vs-AfricanAmerican |
7.224000E-01 |
| Caucasian-vs-Asian |
5.437000E-01 |
| AfricanAmerican-vs-Asian |
5.898000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70414809935937E-12 |
| Normal-vs-Female |
8.08479949654384E-10 |
| Male-vs-Female |
5.699400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.63049999946097E-07 |
| Normal-vs-Extreme_Weight |
1.68376423914651E-12 |
| Normal-vs-Obese |
5.46409995028085E-09 |
| Normal-vs-Extreme_Obese |
4.620500E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.260800E-01 |
| Normal_Weight-vs-Obese |
8.432000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.018800E-01 |
| Extreme_Weight-vs-Obese |
2.652400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.662100E-02 |
| Obese-vs-Extreme_Obese |
4.213600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.11029996097534E-09 |
| Normal-vs-Age(41-60Yrs) |
2.9378999233387E-10 |
| Normal-vs-Age(61-80Yrs) |
4.2061021332529E-11 |
| Normal-vs-Age(81-100Yrs) |
3.58529999999746E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.548000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.018800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.434200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.945170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.123600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.348000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
7.56910000000444E-05 |
| Normal-VS-KIRP CIMP |
1.20160004168923E-09 |
| Normal-VS-Unclassified PRCC |
8.07589994877844E-10 |
| Type1 PRCC-VS-Type2 PRCC |
7.649700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.704800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.909150E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.67230000000818E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
3.684400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.863500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.82000000520577E-08 |
| Normal-vs-N1 |
1.87910000004621E-06 |
| Normal-vs-N2 |
2.11959999999456E-05 |
| N0-vs-N1 |
7.632600E-01 |
| N0-vs-N2 |
1.744820E-03 |
| N1-vs-N2 |
2.262500E-02 |
|
|
